Mark A. Schlossberg

2014

In 2014, Mark A. Schlossberg earned a total compensation of $2.1M as Senior Vice President, General Counsel and Corporate Secretary at Impax Laboratories, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$438,258
Option Awards$584,100
Salary$484,225
Stock Awards$580,520
Other$52,758
Total$2,139,861

Schlossberg received $584.1K in option awards, accounting for 27% of the total pay in 2014.

Schlossberg also received $438.3K in non-equity incentive plan, $484.2K in salary, $580.5K in stock awards and $52.8K in other compensation.

Rankings

In 2014, Mark A. Schlossberg's compensation ranked 4,244th out of 13,032 executives tracked by ExecPay. In other words, Schlossberg earned more than 67.4% of executives.

ClassificationRankingPercentile
All
4,244
out of 13,032
67th
Division
Manufacturing
1,501
out of 4,965
70th
Major group
Chemicals And Allied Products
493
out of 1,690
71st
Industry group
Drugs
381
out of 1,369
72nd
Industry
Pharmaceutical Preparations
304
out of 1,042
71st
Source: SEC filing on April 14, 2015.

Schlossberg's colleagues

We found six more compensation records of executives who worked with Mark A. Schlossberg at Impax Laboratories in 2014.

2014

G Wilkinson

Impax Laboratories

Chief Executive Officer

2014

Larry Hsu

Impax Laboratories

Chief Executive Officer

2014

Carole Ben-Maimon

Impax Laboratories

Former President, Impax Generics Division

2014

Michael Nestor

Impax Laboratories

President, Impax Specialty Pharma division

2014

Bryan Reasons

Impax Laboratories

Chief Financial Officer

2014

Jeffrey Nornhold

Impax Laboratories

Senior Vice President, Technical Operations

You may also like